Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma

Cancer

Volumn 104, Issue 10, 2005, Pages 2048-2053

  Tsutsui, Shinichi ^a   Inoue, Hiroshi ^b   Yasuda, Kazuhiro ^c   Suzuki, Kosuke ^c   Tahara, Kouichirou ^c   Higashi, Hidefumi ^c   Era, Shoichi ^c   Mori, Masaki ^b  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

Author keywords

Breast carcinoma; MIB 1; p27; Prognosis; PTEN

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL CYCLE; CELL NUCLEUS; CORRELATION COEFFICIENT; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTEN GENE; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 27644505704     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21471     Document Type: Article

References (34)

1. Tsutsui S, Inoue H, Yasuda K, et al. The reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast. Oncology. 2005;68:398-404.
2. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387-390.
3. Stambolic V, Suzuki A, Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95:29-39.
4. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL The PTEN/MMAC 1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA. 1998;95:15587-15591.
5. Ramaswamy S, Nakamura N, Vazquez F, Batt SP, Roberts TM, Sellers WR. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A. 1999;96:2110-2115.
6. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943-1947.
7. Freihoff D, Kempe A, Beste B, et al. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer. 1999;79:754-758.
8. Kang Y, Lee HS, Kim WH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest. 2002;82:285-291.
9. Soria JC, Lee HY, Lee JI, et al. Lack of PTEN expression in nonsmall cell lung cancer could be related to promoter methylation. Clin Cancer Res. 2002;8:1178-1184.
10. 1-phase progression. Gene Dev. 1999;13:1501-1512.
11. kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313-323.
12. 1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A. 1998;95:15406-15411.
13. Kip1 into cyclin E/CDK2 complexes. Cancer Res. 1999;59:2318-2323.
14. KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet. 2001;27:222-224.
15. Sun H, Lesche R, Li D, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999;96:6199-6204.
16. Lu Y, Lin Y, LaPushin R, et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene. 1999; 18:7034-7045.
17. kip1. Oncogene. 2000;19:3146-3155.
18. Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res. 2001;61: 2105-2111.
19. Weng L, Brown JL, Eng C. PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet. 2001;10:599-604.
20. Halvorsen OJ, Haukaas SA, Akslen LA. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res. 2003;9:1474-1479.
21. Fenic I, Franke F, Failing K, Steger K, Woenckhaus J. Expression of PTEN in malignant and nonmalignant human prostate tissues: comparison with p27 protein expression. J Pathol. 2004;203:559-566.
22. Dreher T, Zentgraf H, Abel U, et al. Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies. Virchows Arch. 2004;444:509-517.
23. An H, Lee Y, Cho N, et al. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27. Histopathology. 2002;41:437-445.
24. Kurose K, Zhou X, Araki K, Cannistra SA, Maher ER, Eng C. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol. 2001;158:2097-2106.
25. Ermoian RP, Furniss CS, Lamborn KR, et al. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res. 2002;8:1100-1106.
26. Mori M, Mimori K, Shiraishi T, et al. p27 expression and gastric carcinoma. Nat Med. 1997;3:593.
27. Kip1 protein: prognostic implications in primary breast cancer. Nat Med. 1997;3:227-230.
28. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3:231-234.
29. Tsutsui S, Yasuda K, Higashi H, et al. Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer. Breast Cancer. 2004;11:160-168.
30. Kip1 expression. J Biol Chem. 2000;275:24500-24505.
31. Liang J, Zubovitz J, Petrocelli T, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med. 2002;8:1153-1160.
32. kip1. Nature. 2000;404:782-787.
33. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting Forkhead transcription factor. Cell. 1999;96:857-868.
34. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000;20:8969-8982.